Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | GSK5471713 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on GSK5471713 (Feb 2026). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| GSK5471713 | GSK-5471713|GSK 5471713 | Limited information is currently available on GSK5471713 (Feb 2026). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07332455 | Phase Ib/II | GSK5471713 | First-Time-in-Human Study of GSK5471713 in Adults With mCRPC | Recruiting | USA | CAN | 0 |